|
Market Closed -
Nasdaq
00:00:00 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.09% | +182.32% |
| 08-27 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 08-27 | Argenx Completes Acquisition of Forte Biosciences | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 73 | -5.18% | 4 | ||||||
| Average | 73 | -5.18% | 4 | ||||||
| Weighted average by Cap. | 73 | -5.18% | 4 |
- Stock Market
- Stocks
- FBRX Stock
- Sector Forte Biosciences
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
